News
-
When the world fell silent: The role of in silico medicine during the COVID-19 crisis. Part 2/3
In this second article of our series on in silico medicine during the COVID-19 response, we explore how computer models helped optimise vaccine doses, test therapies, as well as simulate immune responses, virtually—saving time, reducing risk, and guiding smarter, faster decisions in a race against the clock.
-Read more-
-
Exploring Trust and Public Engagement in in silico medicine at STS Italia 2025
Delegates from the VPH at the Science and Technology Studies Italia (STS Italia) conference in Milan
-Read more-
-
PhD and postdoc opportunities - June 2025
New calls with deadlines in June/July
-Read more-
-
VPH commends EMA's Mechanistic Modelling Guideline Initiative urging broader scope
On 30 May 2025, VPH presented its formal comments and suggestions on the European Medicines Agency's (EMA) proposed guideline for assessing and reporting mechanistic models in the context of model informed drug development (EMA 2025).
-Read more-
-
New funding opportunities for the in silico medicine community
The European Commission has announced the Health and Research Infrastructures 2025 Work Programmes and these programmes contain several opportunities in the in silico medicine domain.
-Read more-
-
News from the 8th VPH Summer School in Barcelona
The Summer School provides junior engineers, early researchers and medical doctors with an integrative view of state-of-the-art research for in silico medicine, following a complete pipeline from basic science and clinical needs, to model application.
-Read more-
